Gilead price target raised to $95 from $90 at Cowen

Cowen analyst Tyler Van Buren raised the firm’s price target on Gilead to $95 from $90 and keeps an Outperform rating on the shares. The analyst said following the Trodelvy approval in HR+/HER2- mBC on Friday, we have revised and increased our sales estimates in this setting as this is a larger indication than people likely appreciate. .